Join
Live feed
·
NEWSReleasevia Quantisnow
Anixa Biosciences Inc. logo

EXCLUSIVE: Anixa Biosciences Tells Benzinga 'IND follows encouraging findings of necrosis, inflammation and T cell infiltration in tumor biopsy of patient in lowest dose cohort'

ByQuantisnow·Wall Street's wire, on your screen.
ANIX· Anixa Biosciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ANIX (Anixa Biosciences Inc.) and more on Quantisnow.